Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer

Histopathology

Volumn 38, Issue 1, 2001, Pages 13-20

  Setala L ^b   Lipponen, P ^a,b   Tammi, R ^a,b   Tammi, M ^a,b   Eskelinen, M ^b   Alhava, E ^b   Kosma, V M ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

CD44; Gastric cancer; Hyaluronan; Prognosis

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, CD44; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0035151002     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01038.x     Document Type: Article

References (30)

1. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors
2. Molecules in focus. The CD44 protein family
3. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding
4. The normal structure and function of CD44 and its role in neoplasia
5. De-novo expression of CD44 and survival in gastric cancer
6. CD44 and the adhesion of neoplastic cells
7. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: Relation to the proliferation and progression
8. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas
9. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer
10. Expression of CD44 variant 6 and lymphatic invasion: Importance to lymph node metastasis in gastric cancer
11. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: Relation to tumour development and progression
12. Prognostic factors in gastric cancer: The value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration
13. Hyaluronan metabolism in skin
14. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
15. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma
16. Nonparametric estimation from incomplete observation
17. CD44 cell adhesion molecules
18. Forms and functions of CD44
19. Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis
20. Prognostic significance of CD44 and nm23 expression in patients with stage II and IIIa gastric carcinoma
21. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas
22. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants
23. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis
24. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading
25. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus
26. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma
27. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer
28. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential
29. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer
30. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma